PetMed Express (NASDAQ:PETS) Upgraded at Wall Street Zen

PetMed Express (NASDAQ:PETS) was upgraded by Wall Street Zen from a “strong sell” rating to a “hold” rating in a research note issued to investors on Saturday.

Several other research firms also recently weighed in on PETS. Weiss Ratings restated a “sell (d-)” rating on shares of PetMed Express in a research report on Tuesday, May 12th. Zacks Research upgraded shares of PetMed Express to a “hold” rating in a research report on Thursday, April 30th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce”.

PetMed Express Stock Performance

Shares of PetMed Express stock opened at $1.68 on Friday. The firm has a 50-day simple moving average of $2.23 and a two-hundred day simple moving average of $2.60. The company has a market cap of $35.90 million, a P/E ratio of -0.61 and a beta of 0.77. PetMed Express has a fifty-two week low of $1.57 and a fifty-two week high of $4.32.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings results on Tuesday, June 2nd. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.01). PetMed Express had a negative return on equity of 76.86% and a negative net margin of 32.00%.The company had revenue of $42.82 million for the quarter, compared to analyst estimates of $52.00 million. During the same quarter last year, the company earned ($0.56) EPS. Equities research analysts forecast that PetMed Express will post 0.07 EPS for the current year.

Institutional Trading of PetMed Express

Several large investors have recently bought and sold shares of the business. Empowered Funds LLC grew its stake in PetMed Express by 9.3% during the 1st quarter. Empowered Funds LLC now owns 75,024 shares of the company’s stock valued at $171,000 after acquiring an additional 6,373 shares in the last quarter. Sei Investments Co. grew its stake in PetMed Express by 42.0% during the 1st quarter. Sei Investments Co. now owns 23,000 shares of the company’s stock valued at $52,000 after acquiring an additional 6,800 shares in the last quarter. State Street Corp grew its stake in PetMed Express by 7.8% during the 4th quarter. State Street Corp now owns 105,173 shares of the company’s stock valued at $337,000 after acquiring an additional 7,600 shares in the last quarter. Man Group plc grew its stake in PetMed Express by 7.1% during the 3rd quarter. Man Group plc now owns 151,039 shares of the company’s stock valued at $379,000 after acquiring an additional 9,989 shares in the last quarter. Finally, R Squared Ltd grew its stake in PetMed Express by 117.8% during the 3rd quarter. R Squared Ltd now owns 22,127 shares of the company’s stock valued at $56,000 after acquiring an additional 11,970 shares in the last quarter. Hedge funds and other institutional investors own 73.33% of the company’s stock.

PetMed Express Company Profile

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.